Physician

Vimali Paul, M.D.

According to 2025 Medicare claims, Vimali Paul, M.D. (NPI: 1700881448) practices internal medicine in the Chico, CA market, with the plurality of this provider's patient population coming from Butte, CA. This provider's primary affiliated billing organization is VIMALI PAUL MD INC (NPI: 1447518816; TIN: 454832877) and primary practice location at 95973-4964. Paul is affiliated with the Pearl Care 1, LLC (ACO ID: A5557), participating under the MSSP model.

Paul's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 805 traditional Medicare patients, billed 7,381 HCPCS/CPT codes, and received $415,190 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,194 prescription claims across 708 beneficiaries totaling $922,684 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 400 claims. Open Payments data shows 46 records totaling $1,040. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $627,887 to $922,684. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	805	4,826	$306,204
2016	788	5,019	$283,505
2017	831	6,920	$338,739
2018	848	4,757	$293,482
2019	835	4,576	$281,318
2020	836	9,116	$468,605
2021	847	11,518	$601,203
2022	817	7,416	$401,823
2023	797	7,356	$379,469
2024	805	7,381	$415,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	567	9,821	$627,887
2016	597	9,965	$619,131
2017	640	10,157	$712,530
2018	664	10,514	$725,401
2019	673	9,914	$720,058
2020	679	9,631	$716,598
2021	659	9,521	$764,164
2022	694	10,238	$935,353
2023	701	9,800	$1,013,484
2024	708	10,194	$922,684

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	222	982	$65,354
2016	185	847	$40,718
2017	120	665	$36,774
2018	180	769	$33,626
2019	163	819	$22,037
2020	136	804	$36,407
2021	151	686	$43,804
2022	111	647	$36,179
2023	92	623	$52,008
2024	58	400	$40,721

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	495	495	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	556	1,266	$85
90662	Influenza vaccine split virus, preservative free	183	193	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	552	1,167	$60
G0008	Administration of influenza virus vaccine	183	193	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	101	3,195	$108,118
Jardiance	Empagliflozin	52	3,470	$66,047
Ozempic	Semaglutide	49	1,994	$63,785
Eliquis	Apixaban	65	2,990	$56,637
Tresiba Flextouch U-200	Insulin Degludec	42	2,375	$52,596

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	13	83	$23,163
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	19	$5,433
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	53	$5,234
A7031	Face mask interface, replacement for full face mask, each	N	N/R	13	$1,308
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	21	$1,277

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$1,040	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vimali Paul, M.D.?

Tedicare shows public-source Medicare data for Vimali Paul, M.D. (NPI 1700881448), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vimali Paul, M.D. have ACO affiliation data?

Vimali Paul, M.D. is shown with ACO affiliation data for Pearl Care 1, LLC (MSSP, ACO ID A5557).

What billing organization is linked to Vimali Paul, M.D.?

Vimali Paul, M.D. is linked to VIMALI PAUL MD INC (billing NPI 1447518816) in the available physician profile data.

Does Vimali Paul, M.D. have Open Payments data?

Vimali Paul, M.D. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.